Skip to main content
. 2012 Feb 28;2012:786870. doi: 10.1155/2012/786870

Figure 1.

Figure 1

Ranibizumab is a recombinant humanized monoclonal antibody fragment. Bevacizumab is a recombinant humanized IgG antibody. Both bind to and inhibit all biologically active forms of VEGF-A and are derived from the same mouse monoclonal antibody. Ranibizumab has been genetically engineered to bind with higher affinity than bevacizumab (see [8]).